Screening for Depression and Anxiety in Patients With Heart Disease

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03203395

Enrollment

232

Registered

2017-06-29

Start date

2017-01-01

Completion date

2017-10-01

Last updated

2019-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Anxiety Disorders, Collaboration, Depression, Depressive Disorder, Depressive Symptoms, Heart Diseases, Panic Attacks

Keywords

Depression, Anxiety, Panic Attacks, Collaborative Care, Heart disease and depression, Heart disease and anxiety, Heart disease and panic attacks

Brief summary

Depression is a risk factor for morbidity and mortality in patients with heart disease, and has a negative impact on quality of life, work capacity and treatment adherence. Screening for depression among heart patients are therefore recommended by the Norwegian Health Authorities. Also, symptoms of anxiety may negatively affect rehabilitation due to e.g. fear of physical activity and excessive worry. Patients currently receiving treatment for heart disease at Diakonhjemmet Hospital will be screened for symptoms of depression and anxiety. If such symptoms are detected, patients will be offered a counselling session with a clinical psychologist. Further, routines for collaborative communication between clinical psychologist, cardiologist and the patient's general physician will be emphasized.

Interventions

BEHAVIORALScreening and counselling

Screening for symptoms of depression and anxiety in heart patients, giving advice for prevention and managing of such symptoms and stimulating collaborative care between the hospital and the general practitioner.

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

SCREENING

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Men and women over 18 years under treatment for myocardial infarction, heart failure, tachyarrhythmia and/or valvular heart disease at the Department of Internal Medicine, Diakonhjemmet Hospital.

Exclusion criteria

* Unable to provide informed consent. * Unable to read and/or understand Norwegian. * Unable to complete a survey.

Design outcomes

Primary

Measure	Time frame	Description
Detection of symptoms of depression, anxiety and/or recent panic attack in heart patients.	15 minutes	All patients included in the study will be screened for symptoms of depression, anxiety and recent panic attack by filling out a survey consisting of questions from the Patient Health Questionnaire-2 (PHQ-2), the Generalized Anxiety Disorder Scale-2 (GAD-2) and a question about whether they experienced a panic attack in the last four weeks. Cut-off is set to a score of ≥ 2 on PHQ-2 and/or GAD-2 and/or a positive answer on the question about panic attack.
Detection of patients with or at risk for depression and/or anxiety disorders.	1 hour	Patients who screened positive for symptoms of depression, anxiety and/or panic attack will be asked to complete the Hospital Anxiety and Depression Scale (HADS). Patients with a HADS score of ≥ 4 will be offered a counselling session with a clinical psychologist.
Implementation of counselling for treatment and prevention of depression and anxiety disorders in heart patients.	1-2 hours	Patients with a HADS score of ≥ 4 will be offered a counselling session with a clinical psychologist aimed to treat and prevent depression and anxiety disorders in heart patients.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026